Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: IRIDEX Corporation

Market Cap 19.5M 16.85M 15.53M 14.54M 27.27M 1.85B 27.68M 184M 71.59M 902M 73.16M 71.6M 3.12B P/E Ratio 2026 *
-22.4x
P/E Ratio 2027 * 56x
Enterprise Value 19.5M 16.85M 15.53M 14.54M 27.27M 1.85B 27.68M 184M 71.59M 902M 73.16M 71.6M 3.12B EV / Sales 2026 *
0.37x
EV / Sales 2027 * 0.34x
Free-Float
68.77%
Yield 2026 *
-
Yield 2027 * -
1 week+2.75%
Current month+6.67%
1 month+8.74%
3 months-13.85%
6 months+21.63%
Current year-1.75%
1 week 1.09
Extreme 1.09
1.16
1 month 0.98
Extreme 0.98
1.2
Current year 0.95
Extreme 0.9496
1.65
1 year 0.87
Extreme 0.8688
1.65
3 years 0.78
Extreme 0.782
3.65
5 years 0.78
Extreme 0.782
9.46
10 years 0.78
Extreme 0.782
16.64
Manager TitleAgeSince
Chief Executive Officer 54 01/10/2024
Director of Finance/CFO 68 18/12/2018
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 66 17/03/2022
Chairman 77 01/09/2010
Chairman 60 24/06/2020
Date Insider Type Main position Quantity % Market Cap.
06-08Buy

Chief Financial Officer

2,400 0.0138%
06-05Buy

Chief Financial Officer

2,521 0.0145%
06-03Buy

Chief Financial Officer

2,400 0.0138%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+2.75%+19.14%-36.36% 19.5M
-1.33%-0.73%+16.53%-10.78% 174B
-0.45%-2.61%-19.74%+30.31% 146B
-0.38%-2.28%-10.25%-25.35% 127B
-0.55%-3.38%-52.97%-8.31% 69.72B
-0.76%-0.99%+13.25%-2.62% 49.01B
+0.67%-0.60%-24.14%-34.78% 44.74B
+0.22%-4.13%+10.90%+8.65% 36.67B
-1.17%-2.69%+3.87%+35.04% 34.91B
+1.04%+0.79%-9.79%-16.21% 29.65B
Average -0.27%-1.61%-5.32%-6.04% 71.22B
Weighted average by Cap. -0.55%-1.98%-7.27%-2.67%

Financials

2026 *2027 *
Net sales 53M 45.82M 42.21M 39.53M 74.14M 5.04B 75.25M 500M 195M 2.45B 199M 195M 8.49B 56.77M 49.08M 45.21M 42.34M 79.41M 5.4B 80.6M 536M 208M 2.63B 213M 208M 9.09B
Net income -795K -687K -633K -593K -1.11M -75.6M -1.13M -7.5M -2.92M -36.77M -2.98M -2.92M -127M 361K 312K 288K 269K 505K 34.33M 513K 3.41M 1.33M 16.7M 1.35M 1.33M 57.83M
Net Debt - -
Logo IRIDEX Corporation
IRIDEX Corporation is an ophthalmic medical technology company. The Company is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
Employees
93
Date Price Change Volume
12/06/26 1.120 $ 0.00% 22,345
11/06/26 1.120 $ -0.88% 29,365
10/06/26 1.130 $ +0.89% 15,611
09/06/26 1.120 $ +0.90% 87,644
08/06/26 1.110 $ +1.83% 35,560
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.120USD
Average target price
2.750USD
Spread / Average Target
+145.54%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRIX Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!